Biorubin 10mg Injection
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Epirubicin (10mg)
Overview Biorubin 10mg Injection
Rubriox 10mg injection treats various blood cancers, as well as cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used cautiously, either solo or in combination chemotherapy regimens. Dosage and frequency are determined by your physician, depending on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose may cause severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. This medication reduces contraceptive efficacy; reliable birth control is recommended for both partners during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. It can lower blood cell counts, increasing infection risk, potentially life-threatening. Regular blood tests, along with kidney, liver, and heart function monitoring, are essential. Prior to treatment, disclose any liver or heart conditions, and list all other medications, as interactions may affect efficacy or function. Notify your physician of pregnancy or breastfeeding.
Uses of Biorubin 10mg Injection
Malignant neoplasm
Major Benefits of Biorubin 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Biorubin 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Biorubin 10mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not recommended.
How Biorubin 10mg Injection works:
Biorubin 10mg Injection is a cancer therapeutic agent targeting breast cancer. Its mechanism involves topoisomerase II inhibition, disrupting DNA replication in cancerous cells. Concurrently, it generates cytotoxic free radicals, inducing DNA damage and ultimately leading to cell death and tumor growth retardation.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while using Biorubin 10mg Injection.
PregnancyCONSULT YOUR DOCTOR
Administering Biorubin 10mg Injection to pregnant individuals poses a confirmed risk to the fetus and is therefore contraindicated. Exceptions may exist in extreme circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Biorubin 10mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Biorubin 10mg Injection might result in adverse reactions that could compromise driving capabilities. Nausea and vomiting, potential side effects of Biorubin 10mg Injection, may temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
Biorubin 10mg Injection appears to pose minimal risk for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised. A reduced dosage might be warranted for patients exhibiting serum creatinine levels exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should receive Biorubin 10mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Biorubin 10mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Biorubin 10mg Injection :
NA
Facts to Know About Biorubin 10mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Classification | Anthracycline-based drug |
| Potential for Dependence | None. |
| Type of Treatment | Cancer medications |
| Mechanism of Action | Plant-derived anti-cancer compounds |
3,018 People bought this recently